QIAGEN launches new solutions that significantly accelerate DNA variant detection and RNA sequencing of low-input samples

August 9, 2022 QIAseq Targeted DNA Pro Panels halve library preparation time for sequencing samples New low-input kit for RNA sequencing further expands QIAGEN’s universal NGS portfolio and reduces disposable plastics use by 90%  Four million samples have been processed by growing range of QIAseq NGS panels running on any sequencer Hilden, Germany, and Germantown,... Read more

Bio-Rad Acquires Curiosity Diagnostics

August 03, 2022 HERCULES, Calif.–(BUSINESS WIRE)– Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (WSE NewConnect: SCP), a Warsaw, Poland,... Read more

Unchained Labs likes it hot, launches new isothermal applications on Uncle!

July 12, 2022 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job, launched new isothermal applications for biologics and gene therapies on its Uncle platform today. Uncle is the gold standard for measuring protein and AAV stability and with these new applications,... Read more

Bio-Techne Launches New Turbo CE-SDS Cartridge, Accelerating Protein Purity Analysis Throughput by 400%

MINNEAPOLIS, July 12, 2022 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that ProteinSimple, a Bio-Techne brand, has launched the innovative Maurice™ Turbo CE-SDS cartridge. As the name suggests, Turbo enables high speed and high resolution analysis of protein size and purity on Maurice, the flagship capillary electrophoresis (CE) instrument of the iCE family. By providing protein purity results... Read more

Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health

Jun 28, 2022 Investment from LifeArc, Illumina, and Illumina Ventures will fund genomics startups for Illumina Accelerator Cambridge graduates SAN DIEGO, June 28, 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to... Read more

PerkinElmer Introduces New NGS Library Preparation Kits to Accelerate Research and Improve User Experience

Novel updates designed to yield better scientific outcomes and ease of use WHAT: PerkinElmer Inc., a global leader committed to innovating for a healthier world, today announced three new research use only (RUO) library preparation kits: NEXTFLEX® Small RNA-Seq Kit v4, NEXTFLEX® Rapid XP V2 DNA-Seq Kit and PG-Seq™ Rapid Kit v2. HOW: The NEXTFLEX... Read more

Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome

Jun 22, 2022 New assay brings  validated HRD technology from Myriad Genetics to the Illumina TruSight™ Oncology 500, a single, comprehensive pan-cancer test to identify key variants critical for cancer development and progression SAN DIEGO, June 22, 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of a research... Read more